23andme, INC.
A direct to consumer genetic testing company.
Based in CA
🤖
AI Overview
With $135K in lobbying spend across 21 quarterly filings, 23andme, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2019 to 2023.
$135K
Total Spend
5
Years Active
1
Firms Hired
3
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $58K |
| 2020 | $25K |
| 2021 | $26K |
| 2022 | $26K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Consumer Issues, Small Business
- •Regulation of direct to consumer genetic testing
- •Health and data privacy
- •No bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act
- •Data privacy
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.